Diabetes does not influence treatment decisions regarding revascularization in patients with stable coronary artery disease

Diabetes Care

Volumn 29, Issue 9, 2006, Pages 2003-2011

  Breeman, Arno ^a   Bertrand, Michel E ^b   Ottervanger, Jan Paul ^a   Hoeks, Sanne ^c   Lenzen, Mattie ^c   Sechtem, Udo ^d   Legrand, Victor ^e   De Boer, Menko Jan ^a   Wijns, William ^f   Boersma, Eric ^c  

^a Isala Klinieken ^*  (Netherlands)

^b UNIV LILLE   (France)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ROBERT BOSCH HOSPITAL   (Germany)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f CARDIOVASCULAR CENTER   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; INSULIN;

ADULT; ANGIOGRAPHY; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; FATALITY; FEMALE; FOLLOW UP; HAZARD ASSESSMENT; HEALTH SURVEY; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PREVALENCE; PROGNOSIS; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; TREATMENT PLANNING;

AGED; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; EUROPE; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33845296628     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0118     Document Type: Article

References (26)

1. International Diabetes Federation [Internet]. Brussels, International Diabetes Federation. Available from http://www.idf.org/home. Accessed 1 January 2006
2. Coutinho M, Gerstein HC, Wang Y, Yusuf S: The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22:233-240, 1999
3. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl E, Soler-Soler J, Ohrvik J: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: the Euro Heart Survey on Diabetes and the Heart. Eur Heart J 25:1880-1890, 2004
4. The BARI Investigators: Seven-year outcome in the Bypass Angioplasty Re-vascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35:1122-1129, 2000
5. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, Berger PB, Shemin R, Attubato MJ, Williams DO, Frye R, Detre KM: Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation 101:2795-2802, 2000
6. Barsness GW, Peterson ED, Ohman EM, Nelson CL, DeLong ER, Reves JG, Smith PK, Anderson RD, Jones RH, Mark DB, Califf RM: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 96:2551-2556, 1997
7. Abrahams J: Chronic stable angina. N Engl J Med 352:2524-2533, 2005
8. Task Force of the European Society of Cardiology: Management of stable angina pectoris: recommendations of the Task Force of the European Society of Cardiology (Review). Eur Heart J 18:394-413, 1997
9. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug JE, Ruzyllo W, Urban P, Stone GW, Wijns W: Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 26:804-847, 2005
10. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O'Rourke RA, Schafer WP, Williams SV: ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Chronic Stable Angina). Circulation 99:2829-2848, 1999
11. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, Ferguson TB Jr, Fihn SD, Fraker TD Jr, Gardin JM, O'Rourke RA, Pasternak RC, Williams SV, Gibbons RJ, Alpert JS, Antman EM, Hiratzka LF, Fuster V, Faxon DP, Gregoratos G, Jacobs AK, Smith SC Jr, the American College of Cardiology, the American Heart Association Task Force on Practice Guidelines, the Committee on the Management of Patients With Chronic Stable Angina: ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107:149-158, 2003
12. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA, Antman EM, Smith SC Jr, Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK, Ornato JP, the American College of Cardiology, the American Heart Association Task Force on Practice Guidelines, the American Society for Thoracic Surgery and the Society of Thoracic Surgeons: ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:1168-1176, 2004
13. Flaherty JD, Davidson CJ: Diabetes and coronary revascularization. JAMA 293:1501-1508, 2005
14. Rihal CS, Raco DL, Gersh BJ, Yusuf S: Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108:2439-2445, 2003
15. Lenzen MJ, Boersma E, Bertrand ME, Maier W, Moris C, Piscione F, Sechtem U, Stahle E, Widimsky P, de Jaegere P, Scholte op Reimer WJ, Mercado N, Wijns W: Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on Coronary Revascularization. Eur Heart J 26:1169-1179, 2005
16. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R: European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 16:9-13, 1999
17. Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB: A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol 41:1293-1304, 2003
18. Sobel BE, Frye R, Detre KM: Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation 107:636-642, 2003
19. Hordijk-Trion M, Lenzen M, Wijns W, De Jaegere P, Simoons ML, Mercado N, Boersma E: Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularizatison. Eur Heart J 27:671-678, 2006
20. McGuire DK, Anstrom KJ, Peterson ED: Influence of the Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: results from the National Cardiovascular Network Database. Circulation 107:1864-1870, 2003
21. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E: One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. J Thorac Cardiovasc Surg 130:512-519, 2005
22. Stenestrand U, Wallentin L: Early revascularisation and 1-year survival in 14-day survivors of acute myocardial infarction: a prospective cohort study. Lancet 359:1805-1811, 2002
23. Niles NW, McGrath PD, Malenka D, Quinton H, Wennberg D, Shubrooks SJ, Tryzelaar JF, Clough R, Hearne MJ, Hernandez F Jr, Watkins MW, O'Connor GT, the Northern New England Cardiovascular Disease Study Group: Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 37:1008-1015, 2001
24. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE, the SIRIUS Investigators: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349:1315-1323, 2003
25. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME, the TAXUS-IV Investigators: A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221-231, 2004
26. Hill RA, Dundar Y, Bakhai A, Dickson R, Walley T: Drug-eluting stents: an early systematic review to inform policy. Eur Heart J 25:902-919, 2004